𝔖 Bobbio Scriptorium

✦ LIBER ✦

PIN2 RETROSPECTIVE COMPARISON OF TREATMENT OUTCOMES AMONG HEPATITIS C PATIENTS TREATED WITH PEGYLATED INTERFERON 2A OR 2B PLUS RIBAVIRIN AT DIFFERENT VA MEDICAL CENTERS

✍ Scribed by E Dinges; SB Ho; AP Morreale; BK Plowman; A Dollarhide; JM Meyer; P Moise-Broder; S Davis

Book ID: 118608586
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 87 KB
Volume: 10
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)69023-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early HCV-RNA decline during treatment w

Early HCV-RNA decline during treatment with PEG-interferon alfa-2b plus ribavirin or conventional interferon alfa 2b plus ribavirin: analysis of 80 patients treated at a single center: Markus Cornberg, Johannes Hadem, Murat Bastuerk, Hans L Tillmann, Andreas Schueler, Nadine Kothe, Elmar Jaeckel, Christian Trautwein, Heiner Wedemeyer, Michael P Manns, Medizinische Hochschule Hannover, Hannover Germany

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB

PEG-interferon α-2b plus ribavirin for t

PEG-interferon α-2b plus ribavirin for treatment of patients with chronic hepatitis C who have previously failed to achieve a sustained virologic response following interferon α or interferon α-2b plus ribavirin therapy: Mark Sulkowski, Johns Hopkins Medical Institutions, Baltimore, MD; Kenneth D Rothstein, Albert Einstein Medical Ctr, Philadelphia, PA; Lawrence Stein, Florham Park, New Jersey, Florham Park, NJ; Eliot Godofsky, Bradenton, Florida, Bradenton, FL; David Shoultz, PPD Development and University of Washington, Seattle, WA; Russ Hudnall, Mary Huff, Hepatitis Resource Network, Tacoma, WA; Douglas Dieterich, New York University School of Medicine, New York, NY

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Pegylated interferon alfa-2B plus ribavi

Pegylated interferon alfa-2B plus ribavirin in patients with chronic hepatitis C: a trial in prior nonresponders to interferon monotherapy or combination therapy, and in combination therapy relapsers: Ira M Jacobson, Mark W Russo, Weill Medical College of Cornell University, New York, NY; Robert S Brown, Columbia College of Physicians and Surgeons, New York, NY; Edward Lebovics, New York Medical College, Valhalla, NY; Albert Min, Mount Sinai, New York, NY; Stephen Esposito, NYH-Queens, Flushing, NY; Hillel Tobias, NYU Med Ctr, New York, NY; Frank Klion, Mount Sinai, New York, NY; Olga Pizov, Weill Medical College of Cornell University, New York, NY; Cliff Brass, Schering-Plough, Kenilworth, NJ; NY PEG-Intron Study Group, New York, NY

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB